Global Cardiac Rhythm Management Devices Market, 2018-2026 –

The “Global
Cardiac Rhythm Management Devices Market Size, Market Share, Application
Analysis, Regional Outlook, Growth Trends, Key Players, Competitive
Strategies and Forecasts, 2018 To 2026” report has been added
to’s offering.

The cardiac rhythm management devices market was valued at US$ 20.88 Bn
in 2017, and is expected to reach US$ 38.56 Bn by 2026, expanding at a
CAGR of 6.96 % from 2018 to 2026.

Cardiac rhythm management (CRM) devices market shows a lucrative growth
with constant technological advancements driving the market. Advances
such as extended battery life and making devices MRI-safe has created a
positive environment for the growth of this market. Additionally,
enabling wireless functioning of CRM devices and providing
self-monitoring options has contributed to the lucrative growth of CRM
devices market.

The major driver for the CRM market is the rising prevalence of
arrhythmias across the globe. As per the Centers for Disease Control and
Prevention (CDC) atrial fibrillation, the most common form of arrhythmia
accounts for 2.7-6.1 million people in the U.S. as of 2015. The rise in
adoption of unhealthy lifestyles has led to an increased risk of
cardiovascular diseases, which in turn drives the growth of this market.

Reporting of the adverse events such as bleeding or infections caused
upon implantation of CRM devices, may restrain the market growth.
Additionally, the risk of hacking of these devices from an unauthorized
source could possesses a negative impact on the growth of CRM devices
market. In September 2017, the FDA recalled around half million Abbott
pacemakers from the market owing to its cyber security vulnerabilities.
The implanted pacemakers were updated with a new software that enabled

The CRM devices market has worldwide outreach overcoming the unmet needs
of arrhythmia across the globe. North America predominates this market
owing to its vast disposable income, suitable reimbursement plans
pertaining to CRM devices and presence of major manufacturers across
this region. According to the report, National Audit of Cardiac Rhythm
Management Devices by, the pacemaker implant
rate in the U.K. is on a gradual rise, ensuring positive growth of CRM
devices market in Europe.

The cardiac rhythm management devices market comprises a vast
competitive pool, with players constantly striving for advanced
technology. Medtronic Plc. dominates the CRM devices market. Its newest
technology of leadless pacemaker: Micra is expected to change the market
dynamics in the forecast period. Other players holding strong positions
in this market are Abbott Laboratories, Inc., Biotronik, Inc., Boston
Scientific Corporation, Integer Holdings Corporation, LivaNova, Plc.,
Philips Healthcare Informatics, Inc. & ZOLL Medical Corporation.

Key Market Movements:

Companies Mentioned

For more information about this report visit

View source version on